Global Artificial Intelligence in Digital Genome Market Is Expanding Owing To Growing Investments In Artificial Intelligence And Rising Research Activities

 

Artificial Intelligence in Digital Genome Market
Artificial Intelligence in Digital Genome Market

Overview:

The use of artificial intelligence in the drug discovery and development process is increasing at a rapid pace. It can help accelerate the processes and save money in the long run. Moreover, it is capable of producing better results in the market. However, the process of drug discovery and development is very complex. It is a time-consuming and costly process. Artificial intelligence can help in reducing this process. There is a huge demand for artificial intelligence solutions in the manufacturing industry as well. AI can improve decision-making and can help automate accounting processes. Therefore, the market for artificial intelligence in accounting is likely to grow. Key players are developing various product and market strategies to cater to the growing needs of the market. Moreover, they are also expanding their distribution networks.

Market Dynamics:  

 

Rising research and developmental activities is estimated to augment growth of the global artificial intelligence in digital genome market during the forecast period. For instance, U.S. based multinational technology company NVIDIA, developed artificial intelligence and genomic sequencing capabilities in May 2020, for helping researchers in tracking and treating COVID-19. Moreover, lack of a skilled AI professionals and ambiguous regulatory guidelines for medical software is anticipated to restrain growth of the global artificial intelligence in digital genome market during the forecast period.

 

Impact of COVID-19:

 

During the pandemic one of the major challenges was supply of raw materials to manufacturing units for drug discovery. This was caused due to strict travel restrictions imposed in m ay nations. COVID-19 led to increased demand in the medical device manufacturing industry. As the number of COVID-19 patients were increasing large number of medical devices were needed for conducting diagnostic tests, and treating patients. There was an increased demand for drugs and many research institutes and pharmaceutical companies were conducting research for developing vaccines and drugs for battling COVID-19. This augmented the growth of the global artificial intelligence in digital genome market during the pandemic.

Key Takeaways:

 

The global artificial intelligence in digital genome market is estimated to witness robust growth, exhibiting CAGR of XX% during the forecast period, owing to growing government initiatives. For instance, the Department of Biotechnology initiated the Genome India Project in January 2020, for collecting 10,000 genetic samples from Indian citizens.

North America is anticipated to witness significant growth in the global artificial intelligence in digital genome market over the forecast period, due to increasing government initiatives and funding in the region.

Major players operating in the global artificial intelligence in digital genome market are Deep Genomics, NVIDIA Corporation, BenevolentAI, IBM, PrecisionLife Ltd, Microsoft, SOPHiA GENETICS, Fabric Genomics Inc., MolecularMatch Inc., and Verge Genomics.

Comments

Post a Comment

Popular posts from this blog

Recycled Construction Aggregates Market Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Image
  Recycled Construction Aggregates Market Introduction: The Recycled Construction Aggregates Market has gained significant traction in recent years, driven by increasing environmental concerns, resource scarcity, and the growing emphasis on sustainable construction practices. Recycled construction aggregates, derived from the processing and recycling of construction and demolition waste materials, offer several benefits such as reduced demand for virgin materials, decreased landfill waste, and lower carbon footprint. The market for recycled construction aggregates is expected to witness substantial growth and present lucrative opportunities for market players. Market Size and Share: The global recycled construction aggregates market is projected to surpass  6.2 million tons  by the end of 2027 in terms of volume, exhibiting a CAGR of  6.0%  during the forecast period  (2020 to 2027) . The market is driven by stringent environmental regulations, governmen...
Read more

Bispecific Antibodies Are Used As Therapeutic Drugs While Treating Viral Infections, Oncology, And Auto-Immune Diseases

Image
  Bispecific Antibodies Bispecific antibodies are produced through cell fusion or recombinant DNA technologies. Bispecific antibodies are much more specific than monoclonal antibodies. Their applications in tumor immunotherapy are nearly limitless. As of today, seven bispecific antibodies have been approved by the FDA and EMA and over one hundred are in preclinical testing. Bispecific antibodies were initially developed using the quadroma technology. They contain two distinct antigen-binding arms, which enable them to bind to the target antigen while also activating an effector cell, which kills tumor cells. The primary antigen on the surface of the effector cell is called CD3, which is a popular target of immune cells. According to Coherent Market insights the Bispecific Antibodies Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. Many of these multi specific antibody formats have been developed over the past 30 years. These categories ...
Read more

Rising Cancer Cases to boost the Molecular Cytogenetics Market Growth

Image
Molecular Cytogenetics Market Molecular Cytogenetics Market by Products (Kits & Reagents, Instruments, and Software & Services), Technique (Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Karyotyping, Other Techniques), Application (Cancer, Genetic Disorders, Other Applications), And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030 The global Molecular Cytogenetics Market is estimated to be valued at US$ 4,211.4 million in 2023, and is expected to exhibit a CAGR of 24.5 % over the forecast period, as highlighted in a new report published by Coherent Market Insights. Market Overview: Clinical cytogenetics is the examination of the relation between chromosomal alterations and genetic disorders in human beings. Molecular cytogenetics is an examination of genetic diseases utilizing new techniques and methods that link cytogenetic and molecular t...
Read more